418 related articles for article (PubMed ID: 26235620)
21. The synergistic inhibition of breast cancer proliferation by combined treatment with 4EGI-1 and MK2206. Wang H; Huang F; Wang J; Wang P; Lv W; Hong L; Li S; Zhou J Cell Cycle; 2015; 14(2):232-42. PubMed ID: 25607647 [TBL] [Abstract][Full Text] [Related]
22. mTORC2 is required for rit-mediated oxidative stress resistance. PLoS One; ; . PubMed ID: 25531880 [TBL] [Abstract][Full Text] [Related]